img

Global Oral Ursodeoxycholic Acid Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oral Ursodeoxycholic Acid Market Research Report 2024

Ursodeoxycholic acid, whose chemical name is 3a,7β-dihydroxy-5β-cholestane-24-acid, is an organic compound with an odorless, bitter taste. It is used in medicine to increase the secretion of bile acid, change the composition of bile, reduce cholesterol and cholesterol lipid in bile, and help the cholesterol in gallstones to gradually dissolve.
According to Mr Accuracy reports’s new survey, global Oral Ursodeoxycholic Acid market is projected to reach US$ 3436.9 million in 2029, increasing from US$ 1628 million in 2022, with the CAGR of 11.3% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral Ursodeoxycholic Acid market research.
The Ursodeoxycholic Acid (UDCA) drug market is driven by the increasing prevalence of liver and gallbladder disorders and the growing adoption of UDCA as an effective treatment option. UDCA is a naturally occurring bile acid that helps dissolve cholesterol-rich gallstones and aids in the treatment of certain liver diseases, such as primary biliary cholangitis (PBC) and nonalcoholic fatty liver disease (NAFLD). The rise in liver-related conditions and the need for improved therapeutic options contribute to market growth as UDCA offers a well-tolerated and disease-modifying treatment for these disorders. Moreover, advancements in drug formulations and the development of combination therapies have enhanced the efficacy of UDCA treatment. However, the market also faces challenges, including the cost of UDCA drugs and the need for further research to optimize dosing and treatment protocols. Additionally, addressing regulatory requirements and ensuring accessibility to patients can pose obstacles for broader adoption. To succeed, companies must focus on research and development to offer innovative and affordable UDCA drugs, collaborate with hepatologists to optimize treatment approaches, and address the challenges to meet the increasing demand for effective and well-tolerated therapeutic options for liver and gallbladder disorders.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Ursodeoxycholic Acid market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Dr. Falk Pharma
Daewoong Pharmaceutical
Teva
Epic Pharma
Mitsubishi Tanabe Pharma
Lannett
Mylan
Bruschettini
Impax
Shanghai Pharma
Grindeks
Segment by Type
Tablet
Capsule

Segment by Application


Gallstones
Liver Disease
Stomach Trouble
Other

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Oral Ursodeoxycholic Acid report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Oral Ursodeoxycholic Acid Market Overview
1.1 Product Overview and Scope of Oral Ursodeoxycholic Acid
1.2 Oral Ursodeoxycholic Acid Segment by Type
1.2.1 Global Oral Ursodeoxycholic Acid Market Value Comparison by Type (2024-2034)
1.2.2 Tablet
1.2.3 Capsule
1.3 Oral Ursodeoxycholic Acid Segment by Application
1.3.1 Global Oral Ursodeoxycholic Acid Market Value by Application: (2024-2034)
1.3.2 Gallstones
1.3.3 Liver Disease
1.3.4 Stomach Trouble
1.3.5 Other
1.4 Global Oral Ursodeoxycholic Acid Market Size Estimates and Forecasts
1.4.1 Global Oral Ursodeoxycholic Acid Revenue 2018-2029
1.4.2 Global Oral Ursodeoxycholic Acid Sales 2018-2029
1.4.3 Global Oral Ursodeoxycholic Acid Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Oral Ursodeoxycholic Acid Market Competition by Manufacturers
2.1 Global Oral Ursodeoxycholic Acid Sales Market Share by Manufacturers (2018-2024)
2.2 Global Oral Ursodeoxycholic Acid Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Oral Ursodeoxycholic Acid Average Price by Manufacturers (2018-2024)
2.4 Global Oral Ursodeoxycholic Acid Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Oral Ursodeoxycholic Acid, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Ursodeoxycholic Acid, Product Type & Application
2.7 Oral Ursodeoxycholic Acid Market Competitive Situation and Trends
2.7.1 Oral Ursodeoxycholic Acid Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Ursodeoxycholic Acid Players Market Share by Revenue
2.7.3 Global Oral Ursodeoxycholic Acid Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Ursodeoxycholic Acid Retrospective Market Scenario by Region
3.1 Global Oral Ursodeoxycholic Acid Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Oral Ursodeoxycholic Acid Global Oral Ursodeoxycholic Acid Sales by Region: 2018-2029
3.2.1 Global Oral Ursodeoxycholic Acid Sales by Region: 2018-2024
3.2.2 Global Oral Ursodeoxycholic Acid Sales by Region: 2024-2029
3.3 Global Oral Ursodeoxycholic Acid Global Oral Ursodeoxycholic Acid Revenue by Region: 2018-2029
3.3.1 Global Oral Ursodeoxycholic Acid Revenue by Region: 2018-2024
3.3.2 Global Oral Ursodeoxycholic Acid Revenue by Region: 2024-2029
3.4 North America Oral Ursodeoxycholic Acid Market Facts & Figures by Country
3.4.1 North America Oral Ursodeoxycholic Acid Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Oral Ursodeoxycholic Acid Sales by Country (2018-2029)
3.4.3 North America Oral Ursodeoxycholic Acid Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Ursodeoxycholic Acid Market Facts & Figures by Country
3.5.1 Europe Oral Ursodeoxycholic Acid Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Oral Ursodeoxycholic Acid Sales by Country (2018-2029)
3.5.3 Europe Oral Ursodeoxycholic Acid Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Ursodeoxycholic Acid Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Ursodeoxycholic Acid Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Oral Ursodeoxycholic Acid Sales by Country (2018-2029)
3.6.3 Asia Pacific Oral Ursodeoxycholic Acid Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral Ursodeoxycholic Acid Market Facts & Figures by Country
3.7.1 Latin America Oral Ursodeoxycholic Acid Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Oral Ursodeoxycholic Acid Sales by Country (2018-2029)
3.7.3 Latin America Oral Ursodeoxycholic Acid Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Ursodeoxycholic Acid Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Ursodeoxycholic Acid Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Oral Ursodeoxycholic Acid Sales by Country (2018-2029)
3.8.3 Middle East and Africa Oral Ursodeoxycholic Acid Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Ursodeoxycholic Acid Sales by Type (2018-2029)
4.1.1 Global Oral Ursodeoxycholic Acid Sales by Type (2018-2024)
4.1.2 Global Oral Ursodeoxycholic Acid Sales by Type (2024-2029)
4.1.3 Global Oral Ursodeoxycholic Acid Sales Market Share by Type (2018-2029)
4.2 Global Oral Ursodeoxycholic Acid Revenue by Type (2018-2029)
4.2.1 Global Oral Ursodeoxycholic Acid Revenue by Type (2018-2024)
4.2.2 Global Oral Ursodeoxycholic Acid Revenue by Type (2024-2029)
4.2.3 Global Oral Ursodeoxycholic Acid Revenue Market Share by Type (2018-2029)
4.3 Global Oral Ursodeoxycholic Acid Price by Type (2018-2029)
5 Segment by Application
5.1 Global Oral Ursodeoxycholic Acid Sales by Application (2018-2029)
5.1.1 Global Oral Ursodeoxycholic Acid Sales by Application (2018-2024)
5.1.2 Global Oral Ursodeoxycholic Acid Sales by Application (2024-2029)
5.1.3 Global Oral Ursodeoxycholic Acid Sales Market Share by Application (2018-2029)
5.2 Global Oral Ursodeoxycholic Acid Revenue by Application (2018-2029)
5.2.1 Global Oral Ursodeoxycholic Acid Revenue by Application (2018-2024)
5.2.2 Global Oral Ursodeoxycholic Acid Revenue by Application (2024-2029)
5.2.3 Global Oral Ursodeoxycholic Acid Revenue Market Share by Application (2018-2029)
5.3 Global Oral Ursodeoxycholic Acid Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Dr. Falk Pharma
6.1.1 Dr. Falk Pharma Corporation Information
6.1.2 Dr. Falk Pharma Description and Business Overview
6.1.3 Dr. Falk Pharma Oral Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Dr. Falk Pharma Oral Ursodeoxycholic Acid Product Portfolio
6.1.5 Dr. Falk Pharma Recent Developments/Updates
6.2 Daewoong Pharmaceutical
6.2.1 Daewoong Pharmaceutical Corporation Information
6.2.2 Daewoong Pharmaceutical Description and Business Overview
6.2.3 Daewoong Pharmaceutical Oral Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Daewoong Pharmaceutical Oral Ursodeoxycholic Acid Product Portfolio
6.2.5 Daewoong Pharmaceutical Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Oral Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Teva Oral Ursodeoxycholic Acid Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Epic Pharma
6.4.1 Epic Pharma Corporation Information
6.4.2 Epic Pharma Description and Business Overview
6.4.3 Epic Pharma Oral Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Epic Pharma Oral Ursodeoxycholic Acid Product Portfolio
6.4.5 Epic Pharma Recent Developments/Updates
6.5 Mitsubishi Tanabe Pharma
6.5.1 Mitsubishi Tanabe Pharma Corporation Information
6.5.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.5.3 Mitsubishi Tanabe Pharma Oral Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Mitsubishi Tanabe Pharma Oral Ursodeoxycholic Acid Product Portfolio
6.5.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.6 Lannett
6.6.1 Lannett Corporation Information
6.6.2 Lannett Description and Business Overview
6.6.3 Lannett Oral Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Lannett Oral Ursodeoxycholic Acid Product Portfolio
6.6.5 Lannett Recent Developments/Updates
6.7 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Oral Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Mylan Oral Ursodeoxycholic Acid Product Portfolio
6.7.5 Mylan Recent Developments/Updates
6.8 Bruschettini
6.8.1 Bruschettini Corporation Information
6.8.2 Bruschettini Description and Business Overview
6.8.3 Bruschettini Oral Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Bruschettini Oral Ursodeoxycholic Acid Product Portfolio
6.8.5 Bruschettini Recent Developments/Updates
6.9 Impax
6.9.1 Impax Corporation Information
6.9.2 Impax Description and Business Overview
6.9.3 Impax Oral Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Impax Oral Ursodeoxycholic Acid Product Portfolio
6.9.5 Impax Recent Developments/Updates
6.10 Shanghai Pharma
6.10.1 Shanghai Pharma Corporation Information
6.10.2 Shanghai Pharma Description and Business Overview
6.10.3 Shanghai Pharma Oral Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Shanghai Pharma Oral Ursodeoxycholic Acid Product Portfolio
6.10.5 Shanghai Pharma Recent Developments/Updates
6.11 Grindeks
6.11.1 Grindeks Corporation Information
6.11.2 Grindeks Oral Ursodeoxycholic Acid Description and Business Overview
6.11.3 Grindeks Oral Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Grindeks Oral Ursodeoxycholic Acid Product Portfolio
6.11.5 Grindeks Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Ursodeoxycholic Acid Industry Chain Analysis
7.2 Oral Ursodeoxycholic Acid Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Ursodeoxycholic Acid Production Mode & Process
7.4 Oral Ursodeoxycholic Acid Sales and Marketing
7.4.1 Oral Ursodeoxycholic Acid Sales Channels
7.4.2 Oral Ursodeoxycholic Acid Distributors
7.5 Oral Ursodeoxycholic Acid Customers
8 Oral Ursodeoxycholic Acid Market Dynamics
8.1 Oral Ursodeoxycholic Acid Industry Trends
8.2 Oral Ursodeoxycholic Acid Market Drivers
8.3 Oral Ursodeoxycholic Acid Market Challenges
8.4 Oral Ursodeoxycholic Acid Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Oral Ursodeoxycholic Acid Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Oral Ursodeoxycholic Acid Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Oral Ursodeoxycholic Acid Market Competitive Situation by Manufacturers in 2022
Table 4. Global Oral Ursodeoxycholic Acid Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Oral Ursodeoxycholic Acid Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Oral Ursodeoxycholic Acid Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Oral Ursodeoxycholic Acid Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Oral Ursodeoxycholic Acid Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Oral Ursodeoxycholic Acid, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Oral Ursodeoxycholic Acid, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oral Ursodeoxycholic Acid, Product Type & Application
Table 12. Global Key Manufacturers of Oral Ursodeoxycholic Acid, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Ursodeoxycholic Acid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Ursodeoxycholic Acid as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Ursodeoxycholic Acid Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Oral Ursodeoxycholic Acid Sales by Region (2018-2024) & (K Units)
Table 18. Global Oral Ursodeoxycholic Acid Sales Market Share by Region (2018-2024)
Table 19. Global Oral Ursodeoxycholic Acid Sales by Region (2024-2029) & (K Units)
Table 20. Global Oral Ursodeoxycholic Acid Sales Market Share by Region (2024-2029)
Table 21. Global Oral Ursodeoxycholic Acid Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Oral Ursodeoxycholic Acid Revenue Market Share by Region (2018-2024)
Table 23. Global Oral Ursodeoxycholic Acid Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Oral Ursodeoxycholic Acid Revenue Market Share by Region (2024-2029)
Table 25. North America Oral Ursodeoxycholic Acid Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Oral Ursodeoxycholic Acid Sales by Country (2018-2024) & (K Units)
Table 27. North America Oral Ursodeoxycholic Acid Sales by Country (2024-2029) & (K Units)
Table 28. North America Oral Ursodeoxycholic Acid Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Oral Ursodeoxycholic Acid Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Oral Ursodeoxycholic Acid Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Oral Ursodeoxycholic Acid Sales by Country (2018-2024) & (K Units)
Table 32. Europe Oral Ursodeoxycholic Acid Sales by Country (2024-2029) & (K Units)
Table 33. Europe Oral Ursodeoxycholic Acid Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Oral Ursodeoxycholic Acid Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Oral Ursodeoxycholic Acid Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Oral Ursodeoxycholic Acid Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Oral Ursodeoxycholic Acid Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Oral Ursodeoxycholic Acid Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Oral Ursodeoxycholic Acid Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Oral Ursodeoxycholic Acid Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Oral Ursodeoxycholic Acid Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Oral Ursodeoxycholic Acid Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Oral Ursodeoxycholic Acid Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Oral Ursodeoxycholic Acid Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Oral Ursodeoxycholic Acid Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Oral Ursodeoxycholic Acid Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Oral Ursodeoxycholic Acid Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Oral Ursodeoxycholic Acid Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Oral Ursodeoxycholic Acid Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Oral Ursodeoxycholic Acid Sales (K Units) by Type (2018-2024)
Table 51. Global Oral Ursodeoxycholic Acid Sales (K Units) by Type (2024-2029)
Table 52. Global Oral Ursodeoxycholic Acid Sales Market Share by Type (2018-2024)
Table 53. Global Oral Ursodeoxycholic Acid Sales Market Share by Type (2024-2029)
Table 54. Global Oral Ursodeoxycholic Acid Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Oral Ursodeoxycholic Acid Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Oral Ursodeoxycholic Acid Revenue Market Share by Type (2018-2024)
Table 57. Global Oral Ursodeoxycholic Acid Revenue Market Share by Type (2024-2029)
Table 58. Global Oral Ursodeoxycholic Acid Price (US$/Unit) by Type (2018-2024)
Table 59. Global Oral Ursodeoxycholic Acid Price (US$/Unit) by Type (2024-2029)
Table 60. Global Oral Ursodeoxycholic Acid Sales (K Units) by Application (2018-2024)
Table 61. Global Oral Ursodeoxycholic Acid Sales (K Units) by Application (2024-2029)
Table 62. Global Oral Ursodeoxycholic Acid Sales Market Share by Application (2018-2024)
Table 63. Global Oral Ursodeoxycholic Acid Sales Market Share by Application (2024-2029)
Table 64. Global Oral Ursodeoxycholic Acid Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Oral Ursodeoxycholic Acid Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Oral Ursodeoxycholic Acid Revenue Market Share by Application (2018-2024)
Table 67. Global Oral Ursodeoxycholic Acid Revenue Market Share by Application (2024-2029)
Table 68. Global Oral Ursodeoxycholic Acid Price (US$/Unit) by Application (2018-2024)
Table 69. Global Oral Ursodeoxycholic Acid Price (US$/Unit) by Application (2024-2029)
Table 70. Dr. Falk Pharma Corporation Information
Table 71. Dr. Falk Pharma Description and Business Overview
Table 72. Dr. Falk Pharma Oral Ursodeoxycholic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Dr. Falk Pharma Oral Ursodeoxycholic Acid Product
Table 74. Dr. Falk Pharma Recent Developments/Updates
Table 75. Daewoong Pharmaceutical Corporation Information
Table 76. Daewoong Pharmaceutical Description and Business Overview
Table 77. Daewoong Pharmaceutical Oral Ursodeoxycholic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Daewoong Pharmaceutical Oral Ursodeoxycholic Acid Product
Table 79. Daewoong Pharmaceutical Recent Developments/Updates
Table 80. Teva Corporation Information
Table 81. Teva Description and Business Overview
Table 82. Teva Oral Ursodeoxycholic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Teva Oral Ursodeoxycholic Acid Product
Table 84. Teva Recent Developments/Updates
Table 85. Epic Pharma Corporation Information
Table 86. Epic Pharma Description and Business Overview
Table 87. Epic Pharma Oral Ursodeoxycholic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Epic Pharma Oral Ursodeoxycholic Acid Product
Table 89. Epic Pharma Recent Developments/Updates
Table 90. Mitsubishi Tanabe Pharma Corporation Information
Table 91. Mitsubishi Tanabe Pharma Description and Business Overview
Table 92. Mitsubishi Tanabe Pharma Oral Ursodeoxycholic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Mitsubishi Tanabe Pharma Oral Ursodeoxycholic Acid Product
Table 94. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 95. Lannett Corporation Information
Table 96. Lannett Description and Business Overview
Table 97. Lannett Oral Ursodeoxycholic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Lannett Oral Ursodeoxycholic Acid Product
Table 99. Lannett Recent Developments/Updates
Table 100. Mylan Corporation Information
Table 101. Mylan Description and Business Overview
Table 102. Mylan Oral Ursodeoxycholic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Mylan Oral Ursodeoxycholic Acid Product
Table 104. Mylan Recent Developments/Updates
Table 105. Bruschettini Corporation Information
Table 106. Bruschettini Description and Business Overview
Table 107. Bruschettini Oral Ursodeoxycholic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Bruschettini Oral Ursodeoxycholic Acid Product
Table 109. Bruschettini Recent Developments/Updates
Table 110. Impax Corporation Information
Table 111. Impax Description and Business Overview
Table 112. Impax Oral Ursodeoxycholic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Impax Oral Ursodeoxycholic Acid Product
Table 114. Impax Recent Developments/Updates
Table 115. Shanghai Pharma Corporation Information
Table 116. Shanghai Pharma Description and Business Overview
Table 117. Shanghai Pharma Oral Ursodeoxycholic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Shanghai Pharma Oral Ursodeoxycholic Acid Product
Table 119. Shanghai Pharma Recent Developments/Updates
Table 120. Grindeks Corporation Information
Table 121. Grindeks Description and Business Overview
Table 122. Grindeks Oral Ursodeoxycholic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Grindeks Oral Ursodeoxycholic Acid Product
Table 124. Grindeks Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Oral Ursodeoxycholic Acid Distributors List
Table 128. Oral Ursodeoxycholic Acid Customers List
Table 129. Oral Ursodeoxycholic Acid Market Trends
Table 130. Oral Ursodeoxycholic Acid Market Drivers
Table 131. Oral Ursodeoxycholic Acid Market Challenges
Table 132. Oral Ursodeoxycholic Acid Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oral Ursodeoxycholic Acid
Figure 2. Global Oral Ursodeoxycholic Acid Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Oral Ursodeoxycholic Acid Market Share by Type in 2022 & 2029
Figure 4. Tablet Product Picture
Figure 5. Capsule Product Picture
Figure 6. Global Oral Ursodeoxycholic Acid Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Oral Ursodeoxycholic Acid Market Share by Application in 2022 & 2029
Figure 8. Gallstones
Figure 9. Liver Disease
Figure 10. Stomach Trouble
Figure 11. Other
Figure 12. Global Oral Ursodeoxycholic Acid Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Oral Ursodeoxycholic Acid Market Size (2018-2029) & (US$ Million)
Figure 14. Global Oral Ursodeoxycholic Acid Sales (2018-2029) & (K Units)
Figure 15. Global Oral Ursodeoxycholic Acid Average Price (US$/Unit) & (2018-2029)
Figure 16. Oral Ursodeoxycholic Acid Report Years Considered
Figure 17. Oral Ursodeoxycholic Acid Sales Share by Manufacturers in 2022
Figure 18. Global Oral Ursodeoxycholic Acid Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Oral Ursodeoxycholic Acid Players: Market Share by Revenue in 2022
Figure 20. Oral Ursodeoxycholic Acid Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Oral Ursodeoxycholic Acid Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Oral Ursodeoxycholic Acid Sales Market Share by Country (2018-2029)
Figure 23. North America Oral Ursodeoxycholic Acid Revenue Market Share by Country (2018-2029)
Figure 24. United States Oral Ursodeoxycholic Acid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Oral Ursodeoxycholic Acid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Oral Ursodeoxycholic Acid Sales Market Share by Country (2018-2029)
Figure 27. Europe Oral Ursodeoxycholic Acid Revenue Market Share by Country (2018-2029)
Figure 28. Germany Oral Ursodeoxycholic Acid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Oral Ursodeoxycholic Acid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Oral Ursodeoxycholic Acid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Oral Ursodeoxycholic Acid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Oral Ursodeoxycholic Acid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Oral Ursodeoxycholic Acid Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Oral Ursodeoxycholic Acid Revenue Market Share by Region (2018-2029)
Figure 35. China Oral Ursodeoxycholic Acid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Oral Ursodeoxycholic Acid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Oral Ursodeoxycholic Acid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Oral Ursodeoxycholic Acid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Oral Ursodeoxycholic Acid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Oral Ursodeoxycholic Acid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Oral Ursodeoxycholic Acid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Oral Ursodeoxycholic Acid Sales Market Share by Country (2018-2029)
Figure 43. Latin America Oral Ursodeoxycholic Acid Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Oral Ursodeoxycholic Acid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Oral Ursodeoxycholic Acid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Oral Ursodeoxycholic Acid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Oral Ursodeoxycholic Acid Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Oral Ursodeoxycholic Acid Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Oral Ursodeoxycholic Acid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Oral Ursodeoxycholic Acid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Oral Ursodeoxycholic Acid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Oral Ursodeoxycholic Acid by Type (2018-2029)
Figure 53. Global Revenue Market Share of Oral Ursodeoxycholic Acid by Type (2018-2029)
Figure 54. Global Oral Ursodeoxycholic Acid Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Oral Ursodeoxycholic Acid by Application (2018-2029)
Figure 56. Global Revenue Market Share of Oral Ursodeoxycholic Acid by Application (2018-2029)
Figure 57. Global Oral Ursodeoxycholic Acid Price (US$/Unit) by Application (2018-2029)
Figure 58. Oral Ursodeoxycholic Acid Value Chain
Figure 59. Oral Ursodeoxycholic Acid Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries